6505NCM228489: CORONAVIRUS VACCINE.
The CORONAVIRUS VACCINE is a the manufacturer industrial component. Key specifications include cubic_measure: 0.0093 CUBIC FEET, administration: INJECTION, storage_temp_range: +2.0 TO 8.0 CELSIUS DEGC, primary_container_type: VIAL, primary_container_content_quantity: 5.0 MILLILITERS, part_name_assigned_by_controlling_agency: ADULT NOVAVAX, COVID-19 VACCINE, ADJUVANTED MULTI-DOSE VIAL 1S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-702-7190, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| cubic_measure | 0.0093 CUBIC FEET |
| administration | INJECTION |
| storage_temp_range | +2.0 TO 8.0 CELSIUS DEGC |
| unit_package_quantity | 1 |
| primary_container_type | VIAL |
| total_primary_container_quantity | 1 |
| primary_container_content_quantity | 5.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | ADULT NOVAVAX, COVID-19 VACCINE, ADJUVANTED MULTI-DOSE VIAL 1S |
| NSN | 6505-01-702-7190 |
| ADMINISTRATION | INJECTION |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.0 MILLILITERS |
| UNIT PACKAGE QUANTITY | 1 |
| PRIMARY CONTAINER TYPE | VIAL |
| STORAGE TEMP RANGE | +2.0 TO 8.0 CELSIUS DEGC |
| SPECIAL FEATURES | INDICATED FOR ACTIVE IMMUNIZATION TO PREVENT CORONAVIRUS DISEASE 2019(COVID-19) CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2(SARS-COV-2) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER; SUSPENSION FOR INTRAMUSCULAR INJECTION; STORE AT 2C TO 8C (36F TO 46F) DO NOT FREEZE; DISCARD 6 HOURS AFTER FIRST PUNCTURE WHEN STORED AT 2C TO 25C(36F TO 77F); KEEP THE VIAL IN CARTON TO PROTECT FROM LIGHT; 5ML IN A VIAL, MULTI-DOSE(10 DOSES OF 0.5ML); CONTAINS NO PRESERVATIVE; FOR USE UNDER EMERGENCY US AUTHORIZATION. |
| CUBIC MEASURE | 0.0093 CUBIC FEET |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ADULT NOVAVAX, COVID-19 VACCINE, ADJUVANTED MULTI-DOSE VIAL 1S |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |